3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Large B-Cell, Diffuse
40
Lymphoma, Mantle-Cell
28
Lymphoma
27
Lymphoma, Follicular
25
Lymphoma, Non-Hodgkin
23
Leukemia, Lymphocytic, Chronic, B-Cell
22
Lymphoma, B-Cell, Marginal Zone
14
Lymphoma, B-Cell
14
Burkitt Lymphoma
12
Recurrence
11
Precursor Cell Lymphoblastic Leukemia-Lymphoma
8
Neoplasms
8
Waldenstrom Macroglobulinemia
6
Leukemia, Hairy Cell
5
Lymphoproliferative Disorders
4
Leukemia
4
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
3
beta-Thalassemia
2
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
2
Neoplasm, Residual
2
Lymphatic Diseases
2
Leukemia, Myelomonocytic, Chronic
2
Leukemia, Myeloid, Acute
2
Leukemia, Myeloid, Accelerated Phase
2
Leukemia, Biphenotypic, Acute
2
Leukemia, B-Cell
2
Infections
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Epstein-Barr Virus Infections
2
Interventions
Carboplatin
3
durvalumab
2
Tretinoin
2
Paclitaxel
2
Irinotecan
2
zanidatamab
1
veliparib
1
tucatinib
1
trilaciclib
1
trebananib
1
trastuzumab duocarmazine
1
tegafur-gimeracil-oteracil
1
talazoparib
1
sarilumab
1
pexidartinib
1
pertuzumab
1
pembrolizumab
1
patritumab
1
olaparib
1
niraparib
1
neratinib
1
ganitumab
1
dostarlimab
1
cemiplimab
1
abemaciclib
1
Trastuzumab
1
Surgical Procedures, Operative
1
Standard of Care
1
STA 9090
1
SGN-LIV1A
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Pathologic Complete Response
×
Rituximab
×
90 days
×
Clear all
No trials found.